AFP and hepatocellular carcinoma: To our knowledge, several studies have reported that changes in alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) could be used as diagnostic and prognosis biomarkers for HCC [40]–[42].